C40.32
BillableMalignant neoplasm of short bones of left lower limb
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is C40.32 an HCC code?
Yes. C40.32 maps to Breast, Prostate, Colorectal and Other Cancers and Tumors under the CMS-HCC V28 risk adjustment model (and Lymphoma and Other Cancers under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C40.32
For C40.32 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C40.32 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
C40.32 is the ICD-10-CM diagnosis code for malignant neoplasm of short bones of left lower limb. Cancer that starts in the small bones of the left leg or foot, such as the ankle or foot bones. C40.32 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of bone and articular cartilage (c40-c41).
Under the CMS-HCC V28 risk adjustment model, C40.32 maps to Breast, Prostate, Colorectal and Other Cancers and Tumors (HCC 21) with a community, non-dual, aged base RAF weight of 0.545. Under the older CMS-HCC V24 model, C40.32 maps to Lymphoma and Other Cancers (HCC 10) with a community, non-dual, aged base RAF weight of 0.675. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Verify left side laterality is explicitly documented in the medical record. Because C40.32 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C40.32 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Verify left side laterality is explicitly documented in the medical record
- •Short bones of lower limb include tarsal and metatarsal bones; differentiate from long bone involvement which requires different codes
Clinical Significance
Primary malignant neoplasm of the short bones (tarsals, metatarsals) of the left lower limb. These rare bone cancers require careful differentiation from the far more common benign bone tumors of the foot. Documentation of left laterality and specific bone location supports both clinical management and coding accuracy.
Documentation Requirements
- ✓Left-side laterality explicitly documented
- ✓Specific short bone involved (calcaneus, talus, navicular, cuboid, cuneiform, metatarsal)
- ✓Histologic type from pathology
- ✓Primary vs. metastatic origin confirmed
- ✓Imaging and staging details
- ✓Current treatment and disease status